Compare Abbott Laboratories (ABT) vs Home Depot Inc (HD) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Home Depot Inc — how do they compare? Abbott Laboratories trades at $95.48 (market cap $166.94B), while Home Depot Inc trades at $335.74 (market cap $344.21B). The key difference: Home Depot Inc is far larger — about 2.1× Abbott Laboratories's market cap, and Home Depot Inc pays the higher dividend (2.7%). Which is the better fit depends on your goals.
| ABT | HD | |
|---|---|---|
Market Cap | $166.94B | $344.21B |
Sector | Health | Consumer Cyclical |
52-Week High | $136.62 | $423.42 |
52-Week Low | $82.57 | $297.51 |
Enterprise Value | $193.69B | $405.77B |
Dividend Yield | 2.63% | 2.7% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
Home Depot (HD) trades at $336.64, down 4.0% over the past day, reflecting near-term market pressures. The stock shows a bullish technical signal with moving averages supporting upside, while oscillators remain neutral. Fundamentally, revenue grew to $159.51B in 2025 with a net income margin of 8.41%, though margins have compressed from prior years. Recent earnings beat expectations in Q1 2026, but Q3 2025 missed estimates. The company maintains strong profitability with ROE at 128.38% and declared a $2.33 dividend payable in June 2026.
The outlook for HD is cautiously optimistic, supported by analyst consensus and Pro segment growth, but faces headwinds from weakening big-ticket demand and rising mortgage rates. With a consensus price target of $370.59 implying ~10% upside, the stock presents a value opportunity for long-term investors, though margin pressure and housing market volatility pose risks to near-term performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Home Depot Inc
Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.
Read more on HD →
